Acelyrin, Inc.
USD2.27
+0.00 (+0.00%)
CEO
Mina Kim
IPO Date
2023-05-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.27
Prev. Close
$2.27
Day Low
$2.27
Day High
$2.27
52W Low
$1.84
52W High
$7.25
Market Cap
$0.23B
Volume
4.06M
| 11 Dec 2024 |
| HC Wainwright & Co. |
| Neutral |
| Neutral |
| maintain |
| 14 Nov 2024 | HC Wainwright & Co. | Neutral | Neutral | maintain |
| 16 Oct 2024 | Wells Fargo | Overweight | Overweight | maintain |
| 19 Aug 2024 | Morgan Stanley | Equal Weight | Equal Weight | maintain |
| 15 Aug 2024 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 14 Aug 2024 | Piper Sandler | Overweight | Overweight | maintain |
| 8 Jul 2024 | Wells Fargo | Equal Weight | Overweight | upgrade |